Study of KCC Peptide Application in the Colon

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

August 31, 2016

Conditions
Colon PolypsColorectal CancerInflammatory Bowel Disease (IBD)
Interventions
BIOLOGICAL

Colon KCC Heptapeptide

"* Your colonoscopy will happen as it would normally, including the medications, the colonoscope, and any clinically indicated biopsies or polypectomies.~* The fluorescent peptide will be sprayed on to the walls of your colon around the areas that might have a polyp, areas of IBD, or another area of interest. Your doctor will select one area to apply the peptide in your colon. The peptide comes in a single-use sealed vial from the investigational pharmacy. Sterile saline (salt-water) is added to the vial. The powder is mixed well and pulled into a syringe. The peptide is then injected into a special, single-use sprayer, like a garden hose, that fits down the endoscope channel. The peptide will be sprayed in your colon. This is part of the study.~* The endoscopist will take pictures of the area before and after the peptide spraying. They will use the camera that is part of the colonoscope.~* We will obtain copies of your endoscopy report and any pathology reports."

Trial Locations (1)

48109

University of Michigan, Ann Arbor

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Olympus Corporation

INDUSTRY

lead

Danielle Kim Turgeon

OTHER

NCT02156557 - Study of KCC Peptide Application in the Colon | Biotech Hunter | Biotech Hunter